Please select the option that best describes you:
When do you use extended-release buprenorphine instead of daily formulations?
Which patients benefit the most from extended-release buprenorphine formulations such as Sublocade? How have you addressed barriers to accessing these medications?
Answer from: at Academic Institution
Extended-release buprenorphine (e.g., Sublocade, Brixadi) can be a good option for patients who have trouble staying stable on daily sublingual doses, especially those with adherence challenges, ongoing exposure to high-risk opioids such as fentanyl, or concerns about safety and diversion. Clinical ...
Sign In or Register to read more